CYNBIOMEⓇ, your expert partner
Depending on your objectives, we can provide you with support to:
- assess human microbiome therapeutics (LBPs, FMTs)
- evaluate drug or vaccine candidates and microbiota’s influence
- study the relationship between imbalances in microbiota and targeted pathology,
- define the role of microbiota in personalized biotherapeutics.
What makes our offer unique and innovative ?
- A pharma-based approach to the development of human microbiome therapeutics
- An integrated offer to cover the non-clinical development phase
- A panel of complementary & cutting-edge capabilities and expertises
- A modular solution: by expertise, by service, packages of services and customized answer to your needs.
Our collaborative approach
A SCIENTIFIC DRIVEN & COLLABORATIVE SOLUTION TO MEET YOUR OBJECTIVES
Our values
One-stop-shop
Accelerate and derisk the development of your candidates through a unique dedicated preclinical offer.
Innovation
Thanks to our broad range of expertises and innovations, we translate your research into novel therapeutics.
Partnership
We support you in a long-term relationship and help in maximising the added value of your drug candidate.